JP2018529626A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529626A5
JP2018529626A5 JP2017554073A JP2017554073A JP2018529626A5 JP 2018529626 A5 JP2018529626 A5 JP 2018529626A5 JP 2017554073 A JP2017554073 A JP 2017554073A JP 2017554073 A JP2017554073 A JP 2017554073A JP 2018529626 A5 JP2018529626 A5 JP 2018529626A5
Authority
JP
Japan
Prior art keywords
glu
ala
pro
amino acid
synthetic peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017554073A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018529626A (ja
JP6483858B2 (ja
Filing date
Publication date
Priority claimed from CN201610645111.7A external-priority patent/CN106220713B/zh
Application filed filed Critical
Publication of JP2018529626A publication Critical patent/JP2018529626A/ja
Publication of JP2018529626A5 publication Critical patent/JP2018529626A5/ja
Application granted granted Critical
Publication of JP6483858B2 publication Critical patent/JP6483858B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017554073A 2016-08-08 2016-12-26 サソリ毒耐熱合成ペプチド Active JP6483858B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610645111.7A CN106220713B (zh) 2016-08-08 2016-08-08 一种蝎毒耐热合成肽及其用途
CN201610645111.7 2016-08-08
PCT/CN2016/112078 WO2018028117A1 (zh) 2016-08-08 2016-12-26 一种蝎毒耐热合成肽及其用途

Publications (3)

Publication Number Publication Date
JP2018529626A JP2018529626A (ja) 2018-10-11
JP2018529626A5 true JP2018529626A5 (enExample) 2018-12-27
JP6483858B2 JP6483858B2 (ja) 2019-03-13

Family

ID=57547837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017554073A Active JP6483858B2 (ja) 2016-08-08 2016-12-26 サソリ毒耐熱合成ペプチド

Country Status (7)

Country Link
US (2) US10442837B2 (enExample)
EP (1) EP3505530B1 (enExample)
JP (1) JP6483858B2 (enExample)
CN (1) CN106220713B (enExample)
CA (1) CA2984569C (enExample)
ES (1) ES2945407T3 (enExample)
WO (1) WO2018028117A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106220713B (zh) * 2016-08-08 2017-09-01 大连医科大学 一种蝎毒耐热合成肽及其用途
CN109232718B (zh) * 2018-11-09 2020-04-14 泰安市启航生物科技有限公司 一种合成肽sp2及其应用
CN111647051B (zh) * 2019-03-04 2022-02-01 中国医科大学 一种基于钠通道结构的短肽及其应用
CN111896651B (zh) * 2020-07-30 2021-04-23 山东大学 一种白眉蝮蛇蛇毒类凝血酶特征多肽及其应用
CN114028537B (zh) * 2021-11-27 2024-03-29 上海万锦医药科技有限公司 一种含有svhrsp蝎毒肽的药物组合物及其制备方法
CN117224655B (zh) * 2023-09-14 2024-05-14 大连医科大学 蝎毒耐热合成肽(svhrsp)在制备治疗肠道炎症的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1171595C (zh) * 2001-02-19 2004-10-20 大连高新园区全国高技术产业化微生态中试基地 获取无毒有效蝎毒的生产工艺及由该工艺制备的治疗癫痫的药物
US20030235902A1 (en) * 2001-12-13 2003-12-25 Kazuhiko Ishikawa Heat-resistant thioredoxin and related enzymes
CN100465272C (zh) * 2002-01-18 2009-03-04 中国科学院上海有机化学研究所 重组东亚马氏钳蝎毒rBmKaIT1的基因工程
CN100516217C (zh) * 2004-09-22 2009-07-22 山西大学 一种人工合成的蝎氯离子通道神经毒素基因-rBmK CTa
US20070191272A1 (en) * 2005-09-27 2007-08-16 Stemmer Willem P Proteinaceous pharmaceuticals and uses thereof
CN1817902A (zh) * 2006-03-07 2006-08-16 山西大学 一种重组蝎昆虫毒素及其可溶性表达和纯化方法
CN101450966B (zh) * 2007-11-29 2012-06-27 武汉摩尔生物科技有限公司 一种抗耐药菌的多肽及用途
CN101284870B (zh) * 2008-06-03 2011-09-14 武汉大学 一种抗麻疹病毒和人免疫缺陷病毒的多肽及用途
CN103304630B (zh) * 2012-03-07 2014-09-17 中国科学院大连化学物理研究所 东亚钳蝎蝎毒中的gpcr活性多肽及其提取分离和应用
CN104341495A (zh) 2013-07-31 2015-02-11 张万琴 一种蝎毒耐热多肽和制备方法及其应用
CN106220713B (zh) * 2016-08-08 2017-09-01 大连医科大学 一种蝎毒耐热合成肽及其用途

Similar Documents

Publication Publication Date Title
JP2018529626A5 (enExample)
PH12018501912A1 (en) Vaccine against rsv
EP4442816A3 (en) Mutated glycoprotein of vesicular stomatitis virus
JP2017048194A5 (enExample)
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
EA201890220A1 (ru) Вакцина против rsv
JP2016052331A5 (enExample)
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
EP4389898A3 (en) T cell receptors
MX389173B (es) Receptores de celulas t.
IL276210B2 (en) Mers-cov vaccine
PH12018502465A1 (en) Mic-1 compounds and use thereof
JP2019505521A5 (enExample)
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
JP2019214579A5 (enExample)
EP4374913A3 (en) Novel human serum albumin mutant
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
MX2019013801A (es) Compuestos de citocina inhibidora de macrofagos-1 (mic-1) y usos de estos.
WO2015107363A3 (en) Mycobacterial antigen composition
RU2022100555A (ru) Новый пептид
JP2015517484A5 (enExample)
JP2016520534A5 (enExample)
WO2020109780A3 (en) Polypeptide and uses thereof
WO2020152318A3 (en) High growth influenza virus
BR112017014737A2 (pt) formulação de peptídeos inibidores de mk2